Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00912067

Enrollment

120

Registered

2009-06-03

Start date

2009-07-31

Completion date

Unknown

Last updated

2009-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graft Versus Host Disease

Brief summary

The purpose of this study is to evaluate the presence and manifestations of ocular graft versus host disease in adults that had hematopoietic stem cell transplantation in the past 3 years at the sheba medical center, Israel. As well as correlate the degree of the presentation to the therapeutic protocol (chemotherapy and irradiation).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* after hematopoietic stem cell transplantation done at sheba medical center Israel * 3 month have past from transplantation but no more then 3 years

Exclusion criteria

* transplantation done in the last 3 month or more than 3 years have past since

Countries

Israel

Outcome results